Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by PerkinElmer Inc.

PerkinElmer to Hold Earnings Call on Thursday, May 11, 2023
From PerkinElmer Inc.
Via Business Wire
Tickers PKI
PerkinElmer to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
From PerkinElmer Inc.
Via Business Wire
Tickers PKI
PerkinElmer To Hold Earnings Call on Tuesday, February 14, 2023; Updates Fourth Quarter Outlook
From PerkinElmer Inc.
Via Business Wire
Tickers PKI
PerkinElmer to Present at J.P. Morgan Healthcare Conference
From PerkinElmer Inc.
Via Business Wire
Tickers PKI
PerkinElmer Announces its EONIS SCID-SMA Kit is First to Receive Marketing Authorization by U.S. FDA for SMA Screening in Newborns
From PerkinElmer Inc.
Via Business Wire
Tickers PKI
PerkinElmer to Present at 2022 Stifel Healthcare Conference
From PerkinElmer Inc.
Via Business Wire
Tickers PKI
PerkinElmer Bolsters Sustainability Commitments and Builds Off Recent Progress in New ESG Report
From PerkinElmer Inc.
Via Business Wire
Tickers PKI
PerkinElmer Donation Helps Significantly Expand Capacity for Sickle Cell Disease Screening in Ghana
From PerkinElmer Inc.
Via Business Wire
Tickers PKI
PerkinElmer to Present at Upcoming Investor Conferences
From PerkinElmer Inc.
Via Business Wire
Tickers PKI
PerkinElmer and Novartis Collaborate to Address the Unmet Need of Sickle Cell Disease in Sub-Saharan Africa
From PerkinElmer Inc.
Via Business Wire
PerkinElmer’s Horizon Discovery CHOSOURCE™ Platform Expanding To Include CHO-K1 ADCC+ Expression Cell Line for Development of Therapeutic Antibodies in Oncology, Infectious Disease and Autoimmune Conditions
From PerkinElmer Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.